The latest announcement is out from Island Pharmaceuticals Ltd ( (AU:ILA) ).
Island Pharmaceuticals Ltd announced a new issuance of 50,000 fully paid ordinary shares on the Australian Securities Exchange (ASX) with the security code ILA, effective from January 22, 2025. This move could potentially impact the company’s financial position by increasing its equity base, which may support further research and development activities.
More about Island Pharmaceuticals Ltd
Island Pharmaceuticals Ltd operates in the pharmaceutical industry, focusing on the development and commercialization of innovative and proprietary products. The company is involved in the research and development of therapeutics that address unmet medical needs.
YTD Price Performance: 0%
Average Trading Volume: 242,344
Technical Sentiment Consensus Rating: Sell
Current Market Cap: A$30.88M
Learn more about ILA stock on TipRanks’ Stock Analysis page.